Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA MG-132 GDSC1000 pan-cancer AAC 0.018 0.7
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.013 0.8
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.01 0.8
mRNA Panobinostat CCLE pan-cancer AAC -0.013 0.8
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA QL-XII-47 GDSC1000 pan-cancer AAC -0.011 0.8
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.01 0.8
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.017 0.8
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
Download CSV